E-Learning Prototype for Dementia Care for Dementia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Barbara Walkosz, Golden, CO
Dementia+1 More
E-Learning Prototype for Dementia Care - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The mission of corrections is to provide care, custody, and control for incarcerated individuals. United States prisons are required by law to provide adequate care for growing numbers of older people who are incarcerated-a group who are disproportionately at risk for Alzheimer's Disease and Related Dementias (ADRD). This Phase I project focuses on research and development of highly interactive computer-based learning modules, for prison staff and people who are incarcerated and serving as peer caregivers, to promote an integrated systems approach for enhancing the care of people with ADRD in prison.

Eligible Conditions

  • Dementia
  • Prisoners

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Focus groups will conducted in year 1. The analysis will be completed in Year 1 immediately following the conduct of the focus groups.

Year 1
Focus Groups
Year 1
System Usability Scale

Trial Safety

Trial Design

1 Treatment Group

Training Prototype
1 of 1
Experimental Treatment

52 Total Participants · 1 Treatment Group

Primary Treatment: E-Learning Prototype for Dementia Care · No Placebo Group · N/A

Training Prototype
Behavioral
Experimental Group · 1 Intervention: E-Learning Prototype for Dementia Care · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: focus groups will conducted in year 1. the analysis will be completed in year 1 immediately following the conduct of the focus groups.
Closest Location: Barbara Walkosz · Golden, CO
Photo of colorado 1Photo of colorado 2Photo of colorado 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Dementia
0 CompletedClinical Trials

Who is running the clinical trial?

Penn State UniversityOTHER
310 Previous Clinical Trials
114,380 Total Patients Enrolled
9 Trials studying Dementia
2,906 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,348 Previous Clinical Trials
3,261,845 Total Patients Enrolled
200 Trials studying Dementia
891,035 Patients Enrolled for Dementia
Klein Buendel, Inc.Lead Sponsor
31 Previous Clinical Trials
29,267 Total Patients Enrolled
Susan LoebPrincipal InvestigatorPenn State University

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are able to consent.
You have experience in caring for a person with a disability.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.